The Human Biome · Article 11 of 26
Soil Probiotics (Soil-Based Organisms): Origins, Properties, and Comparison with Conventional Probiotics
Educational and scope notice
This material is for education only and does not provide medical diagnosis or treatment advice. IEMT practitioners should remain within their professional scope and refer clients to an appropriately qualified healthcare professional where medical assessment, treatment, prescribed medication, supplements or restrictive diets are involved.
Soil probiotics, also known as Soil-Based Organisms (SBOs), refer to naturally occurring, spore-forming microorganisms originally derived from healthy soil ecosystems. These species co-evolved with humans through continual contact with the environment, plants, and unprocessed foods. Unlike conventional lactic acid–based probiotics, which are primarily isolated from fermented foods, soil probiotics are resilient environmental strains that can survive extremes of temperature, oxygen, and acidity.
1. Origin and Composition
Historically, humans ingested a small number of soil microbes daily through unwashed vegetables, wild herbs, and direct contact with the earth. Modern sanitation and food processing have largely removed this environmental exposure. Soil probiotics aim to reintroduce these environmental commensals to support immune and gastrointestinal balance.
Common genera in commercial or research formulations include Bacillus subtilis, Bacillus coagulans, Bacillus clausii, Bacillus indicus, and Bacillus licheniformis. These organisms are typically spore-formers, encased in a natural protective shell that allows them to survive stomach acid, bile salts, and ambient storage without refrigeration. Some preparations also contain soil-derived Lactobacillus and Clostridium butyricum strains.
2. Distinction from Conventional Probiotics
Conventional probiotics (such as Lactobacillus acidophilus, Bifidobacterium bifidum, and Streptococcus thermophilus) are derived from fermented dairy or plant products. They require careful handling, refrigeration, and continuous ingestion to maintain presence in the gut, as most are non-spore-forming and transient.
By contrast, Soil-Based Organisms demonstrate several distinct features:
• Environmental origin: SBOs are native to soil and plant rhizospheres rather than dairy or human intestinal sources.
• Spore-forming capability: Their protective coat allows survival through gastric acidity, enabling survival through gastric acidity and transient interaction with the intestinal environment.
• Shelf stability: They remain viable without refrigeration for extended periods, increasing product stability.
• Transient colonisation: While robust, they generally do not permanently colonise the gut but exert effects through immune modulation and the competitive exclusion of pathogens.
• Immunological activity: Soil species interact strongly with gut-associated lymphoid tissue (GALT), training immune tolerance and enhancing mucosal defence.
• Lower dependence on prebiotics: Spore-formers can germinate and proliferate in diverse intestinal environments, even with low dietary fibre intake, whereas lactic acid strains rely heavily on fermentable substrates.
3. Proposed Mechanisms of Action
Research suggests several overlapping mechanisms for soil probiotics:
• Competitive exclusion: SBOs inhibit pathogenic bacteria such as Clostridium difficile and Escherichia coli by producing antimicrobial peptides and occupying adhesion sites.
• Immune modulation: Exposure to non-pathogenic soil organisms promotes balanced Th1/Th2 immune responses, reducing allergic and inflammatory tendencies.
• Short-chain fatty acid production: Some SBOs ferment undigested carbohydrates to yield butyrate and propionate, supporting colonic epithelial health.
• Gut–brain axis effects: Animal models indicate possible indirect influence on serotonin and GABA signalling, though human evidence is preliminary.
4. Clinical and Experimental Evidence
Several clinical studies have evaluated individual soil species:
• Bacillus clausii: Widely studied for antibiotic-associated diarrhoea. Multiple randomised controlled trials demonstrate reduced incidence and duration of diarrhoea and improved stool consistency. Recognised as a safe adjunct probiotic by the World Health Organisation (WHO) and used clinically in parts of Europe and Asia.
• Bacillus coagulans: Demonstrated benefits for irritable bowel syndrome (IBS), functional bloating, and immune modulation in small clinical trials. Its spore-forming ability supports high survivability through gastric transit.
• Bacillus subtilis: Historically known as “Natto bacillus”, is used in Japanese fermented soybean products. Research shows roles in vitamin K2 synthesis, immune stimulation, and inhibition of enteric pathogens.
Evidence for mood or neurocognitive effects of SBOs remains limited but emerging. Animal studies suggest reductions in stress-induced corticosterone and inflammatory cytokines following Bacillus supplementation, indicating potential relevance to gut–brain interaction research.
5. Safety Considerations
Most Bacillus species used in dietary supplements have Qualified Presumption of Safety (QPS) or Generally Recognised as Safe (GRAS) status when manufactured under GMP standards. However, improper identification or contamination with opportunistic species (e.g., Bacillus cereus) can pose risks, particularly in immunocompromised individuals.
Key safety distinctions include:
• Use only validated commercial strains with established safety profiles (e.g., Bacillus clausii, B. coagulans).
• Avoid unverified “soil-derived” DIY cultures or non-clinical environmental isolates.
• Reported adverse events are rare but have included transient bloating or mild gastrointestinal discomfort during early adaptation.
Safety and Mislabelling of Soil-Based Probiotics
While soil-based probiotics (SBOs) are marketed as natural and resilient alternatives to conventional probiotic strains, their growing popularity has outpaced regulatory oversight. Independent testing and published case reports highlight several safety and labelling concerns that practitioners should understand before suggesting these products.
1. Misidentification and Strain Ambiguity
Many commercial SBO supplements list only “soil-based organisms” or “proprietary spore blend” without identifying the exact species or strain. This obscures safety verification, as different Bacillus species vary greatly in pathogenic potential. For example, Bacillus subtilis is generally safe, whereas Bacillus cereus and B. anthracis are pathogenic. Accurate strain identification and deposition in recognised culture collections (e.g., ATCC, DSMZ) are essential for validation and reproducibility.
2. Contamination and Quality Control Failures
Several analyses have revealed contamination of unregulated probiotic supplements with opportunistic or antibiotic-resistant bacteria. Poor manufacturing hygiene or unverified environmental sourcing can introduce spore-forming pathogens or heavy-metal residues from soil. In 2021, the U.S. Food and Drug Administration (FDA) issued cautionary notices regarding unapproved “spore-based” probiotics sold online that contained unlisted species and lacked safety data.
3. Exaggerated Health Claims
Some companies promote soil probiotics as “ancestral microbiome restorers” or claim they can treat depression, autism, autoimmune diseases, or chronic fatigue. These claims have no clinical substantiation and risk misleading consumers. The current evidence base supports only modest benefits for gut function and certain diarrhoeal conditions, not psychiatric or systemic disease treatment.
4. Risks for Vulnerable Populations
Although rare, invasive infections from Bacillus species have been reported in immunocompromised patients and infants, especially when non-sterile preparations were used. Practitioners should avoid recommending SBOs to individuals with severe illness, immunosuppression, or central venous lines.
5. Responsible Selection
To minimise risk:
• Choose supplements that clearly list genus, species, and strain (e.g., Bacillus clausii UBBC-07).
• Verify products manufactured under Good Manufacturing Practice (GMP) with third-party microbial testing.
• Avoid any product describing ingredients only as “soil organisms”, “earth cultures,” or “ancestral spores” without specification.
• Emphasise that “natural” does not automatically mean “safe” or “clinically effective”.
6. Comparison Summary: Soil vs. Conventional Probiotics
| Characteristic | Soil-Based Organisms (SBOs) | Conventional Probiotics |
|---|---|---|
| Origin | Environmental/soil-derived species | Fermented food or human gut isolates |
| Major genera | Bacillus spp. Clostridium butyricum | Lactobacillus Bifidobacterium |
| Form | Spore-forming Shelf-stable | Non-spore Refrigeration often required |
| Survival through stomach acid | High (spores resist gastric pH) | Low to moderate |
| Colonisation | Transient Modulates local ecology | Transient Dependent on daily intake |
| Main actions | Immune modulation Antimicrobial peptide production Gut barrier support | Lactic acid production Digestion aid Microbiome balance |
| Evidence base | Growing Strain-specific Several RCTs for diarrhoea | Extensive Strong evidence for IBS Antibiotic-associated diarrhoea |
7. Practical and Ethical Considerations
Practitioners should interpret claims regarding soil probiotics cautiously. While some clinical data are promising, marketing often overstates benefits and neglects safety controls. Use only products that identify strains clearly, provide third-party testing, and comply with international probiotic safety guidelines. Unregulated “soil extract” supplements or DIY preparations may contain pathogenic contaminants.
Within an educational framework, soil probiotics provide a powerful metaphor for environmental–microbial symbiosis: just as healthy soil sustains plant life, a balanced internal ecosystem supports human wellbeing. The responsible application of this concept lies in evidence-based practice, not in unverified or speculative therapies.
References
- Cutting, S.M. (2011). Bacillus probiotics. Food Microbiology, 28(2), 214–220.
- Green, J., & Sheth, A. (2019). Soil-Based Organisms as Probiotics: A Review. Journal of Functional Foods, 56, 142–150.
- Duc, L.H. et al. (2004). Characterisation of Bacillus probiotics and safety considerations. Applied and Environmental Microbiology, 70(8), 4951–4959.
- Soman, R. et al. (2020). Bacillus clausii as a probiotic in the prevention of antibiotic-associated diarrhoea. World Journal of Clinical Cases, 8(12), 2476–2486.
- Tamang, J.P. et al. (2022). Probiotics and fermented foods: traditional and next-generation perspectives. Frontiers in Microbiology, 13, 831227.